Circulatory support of the sick preterm infant

Seminars in Neonatology

Volumn 6, Issue 1, 2001, Pages 85-95

  Seri, Istvan ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dex amethasone; Dobutamine; Dopamine; Epinephrine; Hydrocortisone; Hypotension; Hypovolemia; Myocardial dysfunction; Peripheral vasoregulation; Preterm infant

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR; DOBUTAMINE; DOPAMINE; ISOTONIC SOLUTION; NORADRENALIN; STEROID;

ADRENAL INSUFFICIENCY; ASSISTED CIRCULATION; DRUG CHOICE; HEART OUTPUT; HUMAN; HYPOTENSION; INFANT; MYOCARDIAL DISEASE; NEWBORN; ORGAN BLOOD FLOW; PREMATURITY; RECEPTOR DOWN REGULATION; RESUSCITATION; REVIEW; SHOCK; TISSUE PERFUSION;

EID: 0035151088     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1053/siny.2000.0034     Document Type: Article

References (58)

1. Shock in the pediatric patient
2. Effect of dopamine on regional blood flows in sick preterm neonates
3. Blood pressure measurements in the newborn
4. Mean arterial blood pressure changes in premature infants and those at risk for intraventricular hemorrhage
5. Blood pressure monitoring in the newborn
6. Cardiovascular, renal, and endocrine actions of dopamine in neonates and children
7. Cardiac function in the shocked very low birth weight infant
8. Relation between arterial blood pressure and blood volume and effect of infused albumin is sick preterm infants
9. Blood pressure and blood volume in preterm infants
10. Randomized controlled trial of plasma protein fraction versus dopamine in hypotensive very low birth weight infants
11. Nutritional management and the multisystem organ failure/systemic inflammatory response syndrome in critically ill preterm neonates
12. Cardiogenic shock associated with perinatal asphyxia in preterm infants
13. Low neonatal cerebral oxygen delivery is associated with brain injury in preterm infants
14. Blood pressure and cerebral hemorrhage and ischemia in very low birth weight infants
15. Influence of acidosis, hypoxemia, and hypotension on neurodevelopmental outcome in very low birth weight infants
16. Low cerebral blood flow is a risk factor for severe intraventricular haemorrhage
17. Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants
18. Acid base, fluid and electrolyte management in the newborn
19. Cardiovascular response to dopamine in hypotensive preterm infants with severe hyaline membrane disease
20. Dopamine pharmacokinetics in critically ill newborn infants
21. Effects of low-dose dopamine on cardiovascular and renal functions, cerebral blood flow, and plasma catecholamine levels in sick preterm neonates
22. Randomised controlled trial of colloid infusions in hypotensive preterm infants
23. Randomised controlled trial of colloid or crystalloid in hypotensive preterm infants
24. Distribution of normal saline and 5% albumin infusions in septic patients
25. A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of vascular leak syndrome associated with interleukin-2 therapy
26. Albumin: Saint or sinner?
27. Response to dobutamine and dopamine in the hypotensive very preterm infant
28. Peripheral oxygenation in hypotensive preterm babies
29. Impact on blood pressure and intestinal perfusion of dobutamine or dopamine in hypotensive preterm infants
30. +-ATPase activity in renal cortical tubule cells
31. Dopamine and dobutamine in pediatric therapy
32. Developmental aspects of alpha- and beta-adrenergic receptors
33. Turning off the signal: Desensitization of β-adrenergic receptors
34. Adrenocortical function in the very low birth weight infant: Improved testing sensitivity and association with neonatal outcome
35. Prophylaxix against early adrenal insufficiency to prevent chronic lung disease in premature infants
36. Effect of high-dose dopamine on urine output in newborn infants
37. Addition of epinephrine to dopamine increases blood pressure and urine output in critically ill extremely low birth weight neonates with uncompensated shock
38. The pharmacology of dobutamine
39. Response to dopamine and dobutamine in the preterm infant lass than 30 weeks gestation
40. Randomized trial comparing dopamine and dobutamine in preterm infants
41. Randomized, blind trial of dopamine versus dobutamine for treatment of hypotension in preterm infants with respiratory distress syndrome
42. Dopamine versus epinephrine for inotropic support in the neonate: A randomized double blinded controlled trial
43. Clinical experience with norepinephrine infusions in critically ill newborns
44. Hemodynamic support: Volume management and pharmacological cardiovascular support
45. Single-dose dexamethasone treatment of hypotension in preterm infants
46. Cardiovascular instability (CVI) in ventilated neonates: A double-blind controlled trial of hydrocortisone supplementation
47. Rapid increase of blood pressure in extremely low birth weight infants after a single dose of dexamethasone
48. Glucocorticoid-responsive hypotension in extremely low birth weight newborns
49. Early postnatal dexamethasone increases blood pressure and improves pulmonary function in ELBW neonates
50. A single large dose of dexamethasone improves outcome of perinatal sepsis syndrome at term
51. Cardiovascular effects of hydrocortisone in preterm neonates with pressor-resistant hypotension
52. Regulation of b-adrenergic receptors by 'permissive' hormones: Corticosteroids increase the steady-state levlls of receptor mRNA
53. Specific, nongenomic actions of steroid hormones
54. Randomized trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birth weight infants
55. Risk factors for early intestinal perforation among low birth weight neonates enrolled in a trial of early dexamethasone therapy
56. Disseminated candidal infections and intravenous hydrocortisone in preterm infants
57. Effect of a 42-day tapering course of dexamethasone on outcome at one year of age in very preterm infants
58. Hemodynamic effects of sodium bicarbonate in critically ill neonates